MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.95
+0.42 (3.35%)
At close: Aug 13, 2025, 4:00 PM
12.95
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:48 PM EDT
MBX Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts that cover MBX Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $37.57, which forecasts a 190.12% increase in the stock price over the next year. The lowest target is $30 and the highest is $44.
Price Target: $37.57 (+190.12%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Initiates $38 | Buy | Initiates | $38 | +193.44% | Aug 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $38 | Buy | Initiates | $38 | +193.44% | Jul 16, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +193.44% | Apr 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +239.77% | Apr 10, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +170.27% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.73
from -5.82
EPS Next Year
-2.69
from -2.73
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.48 | -2.33 | -2.53 |
| Avg | -2.73 | -2.69 | -3.24 |
| Low | -2.96 | -3.14 | -3.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.